Deborah B Doroshow (Deborah Doroshow)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Dna Damage Response

Pulmonary Hypertension

Top Venues

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Deborah B Doroshow, Peter H O'Donnell, Jean H Hoffman-Censits, Sumati V Gupta, Ulka N Vaishampayan, Elisabeth I Heath, Philip Garcia, Qianqian Zhao, Menggang Yu, Matthew I Milowsky, Matthew D Galsky
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations. JCO precision oncology 7 (2023)
Joseph Paul Eder, Deborah B Doroshow, Khanh T Do, Vicki L Keedy, Jeffrey S Sklar, Peter M Glazer, Ranjit Bindra, Geoffrey I Shapiro
Clinical Efficacy of Olaparib in IDH1/IDH2- Mutant Mesenchymal Sarcomas. JCO precision oncology 5 (2022)
Haider Mahdi, Navid Hafez, Deborah B Doroshow, Davendra Sohal, Vickie Keedy, Khanh T Do, Patricia LoRusso, Juliane Jürgensmeier, Manuel Avedissian, Jeffrey S Sklar, Colin Glover, Brunella Felicetti, Emma Dean, Peter G S Mortimer, Geoffrey I Shapiro, Joseph Paul Eder
Ceralasertib-Mediated ATR Inhibition Combined With Olaparib in Advanced Cancers Harboring DNA Damage Response and Repair Alterations (Olaparib Combinations). JCO precision oncology 5 (2021)